Danish start-up works on an RNA molecule to treat neurological disorders such as epilepsy and Parkinson's disease
Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases
Two books, two first works, two authors: Luca Guido Zambrelli and Luca Zorloni, two stories that tell the possible future in the form of a novel
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.